Cramer's charts suggest big-name biotech stocks Gilead and Celgene have more room to run
July 17, 2018 at 18:45 PM EDT
Jim Cramer and technician Bob Lang inspect the charts to see if big-cap biotechnology stocks like Gilead and Celgene could have more room to run.